Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China
· Delayed Price · Currency is CNY 85.60
+0.10 (0.12%)
Aug 15, 2025, 3:00 PM CST
Xiamen Amoytop Biotech Revenue
Xiamen Amoytop Biotech had revenue of 673.35M CNY in the quarter ending March 31, 2025, with 23.48% growth. This brings the company's revenue in the last twelve months to 2.95B, up 32.29% year-over-year. In the year 2024, Xiamen Amoytop Biotech had annual revenue of 2.82B with 34.13% growth.
Revenue (ttm)
2.95B
Revenue Growth
+32.29%
P/S Ratio
11.82
Revenue / Employee
1.22M
Employees
2,423
Market Cap
34.82B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| WuXi AppTec | 41.48B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |